Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780) |
---|
04/01/2008 | US7351838 First reactive functional group used to provide attachment to a surface of a substrate, second reactive functional group is a N-sulfonyldicarboximide group reacted with an amine-containing material, to form a connector group between the substrate and amine containing material (protein, peptide, dna rna) |
04/01/2008 | US7351825 4-[5-((1S,2R)-1-Carboxy-2-phenyl-cyclopropylsulfamoyl)-thiophen-2-yl]-3,6-dihydro-2H-pyridine-1-carboxylic acid tert-butyl ester; aggrecanase and matrix metalloproteinase (with zinc in the catalytic active center) (MMP) inhibitor; antiarthritic agent: osteoarthritis, rheumatoid arthritis |
04/01/2008 | US7351807 Cyanine-sulfenates for dual phototherapy |
04/01/2008 | US7351733 Tetrahydrocarbazole derivatives and their pharmaceutical use |
04/01/2008 | US7351730 Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1) |
04/01/2008 | US7351719 Amide compounds having MCH-antagonistic activity and medicaments comprising these compounds |
04/01/2008 | US7351705 Carboxylic acid compounds and a pharmaceutical agent comprising the compound as the active ingredient |
04/01/2008 | US7351703 Which modulate the endogenous production of cyclic guanosine monophosphate (cGMP); for therapy and prophylaxis of cardiovascular disorders such as high blood pressure, angina pectoris, cardiac insufficency, thromboses, and/or atherosclerosis |
04/01/2008 | US7351702 Caspase inhibitors and uses thereof |
04/01/2008 | CA2471952C Fluoro substituted cycloalkanoindoles and their use as prostaglandin d2 receptor antagonists |
04/01/2008 | CA2446574C Liquid pharmaceutical composition |
04/01/2008 | CA2049867C N-alkylphthalimide mixtures for use as carriers in dyeing and optical brightening |
03/27/2008 | WO2008009924A3 Indoles useful in the treatment of inflammation |
03/27/2008 | WO2008004088A3 Iron-copper co-catalyzed process for carbon-carbon or carbon-heteroatom bonding |
03/27/2008 | WO2008002674A3 Bicyclic compositions and methods for modulating a kinase cascade |
03/27/2008 | WO2007146717A3 Process for making salts of n-hydroxy-3-[4-[[[2-(2-methyl-1h-indol-3-yl)ethyl]amino]methyl]phenyl]-2e-2-propenamide |
03/27/2008 | US20080076815 Sulfonamide or sulfonimide functional indazole or indole compounds such as N-[3-[2-[2-(3-methylindazol-6-yloxy)ethylamino]-1-hydryoxyethyl]phenyl]methanesulfonamide; diabetes, obesity, hyperlipidemia and urinary incontinence |
03/27/2008 | US20080076796 Methods and Compositions for the Treatment of Alcoholism and Alcohol Dependence |
03/27/2008 | US20080076775 3-(2-alkoxycarbonyl-3-indolyl)-3-oxo-propionic acid ester or propionamide intermediates: methyl 3-[6-fluoro-2-(methoxycarbonyl)-1-methyl-1H-indol-3-yl]-3-oxopropanoate; peripheral neuropathy, Parkinson's disease, Alzheimer's disease |
03/27/2008 | US20080076738 antiviral: improved pharmacokinetics |
03/27/2008 | US20080076188 Luminescent compounds |
03/27/2008 | US20080075773 Solid oral composition comprising 3-(5-methoxy-1H-indol-3-yl-methylene)-N-pentylcarbazimidamide or salt and disintegrant comprising crospovidone, sodium starch glycolate, carboxymethylcellulose sodium, sodium alginate; for administering active agents which are poorly soluble in water or acid sensitive |
03/27/2008 | DE102005038632B4 Acyltryptophanole Acyltryptophanole |
03/27/2008 | CA2662838A1 Oxindole derivatives |
03/26/2008 | EP1903030A1 Method for catalytic manufacture of aromatic or heteroaromatic nitriles |
03/26/2008 | EP1902027A1 3-spir0cycl0pr0pyl2-0xind0le kinase inhibitors |
03/26/2008 | EP1902026A2 Tetrahydrocarbazole derivatives useful as androgen receptor modulators (sarm) |
03/26/2008 | EP1902025A1 Kinase inhibitors |
03/26/2008 | EP1902024A2 Kinase inhibitors |
03/26/2008 | EP1902023A2 Improved process for preparing insecticidal (disubstitutedpropenyl) phenylalkyl substituted heterocycles |
03/26/2008 | EP1668091B1 Fluorescent compound |
03/26/2008 | EP1641754B1 Process and intermediates for the preparation of (1r, 2s, 5s)-3- azabicyclo[ 3, 1, 0]hexane-2-carboxamide, n- [3-amino -1-(cyclobutylmethyl)-2, 3-dioxopropyl] ]-3- [ (2s)- 2-[[[1, 1-dimethylethyl ]amino]carbonyla mino ]-3, 3-dimethyl-1-oxobutyl] -6, 6-dimethyl |
03/26/2008 | EP1633716A4 Biarylmethyl indolines, indoles and tetrahydroquinolines, useful as serine protease inhibitors |
03/26/2008 | CN101151255A 5-phenyl-pentanoic acid derivatives as matrix metalloproteinase inhibitors for the treatment of asthma and other diseases |
03/26/2008 | CN101151246A 1-benzylindole-2-carboxamide derivatives |
03/26/2008 | CN101151245A Indan-amide derivatives with glycogen phosphorylase inhibitory activity |
03/26/2008 | CN101151031A Tricyclic cytoprotective compounds |
03/26/2008 | CN101151026A O-desmethylvenlafaxine and bazedoxifene combination product and uses thereof |
03/26/2008 | CN100377006C Hydrazone-based charge transport materials |
03/26/2008 | CN100377005C Organophotoreceptor with charge transport compound with an azine group |
03/26/2008 | CN100376579C 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino[4,5-b]indole-1-carboxamide derivatives, their preparation and use in treating |
03/26/2008 | CN100376577C Method for preparing vindoline and Catharanthine |
03/26/2008 | CN100376556C Preparation method of 2-azabicyclo[3,3,0] octane-1-carboxylic acid hydrochloride |
03/26/2008 | CN100376555C Process for preparing diindolylmethane derivatives |
03/26/2008 | CN100376554C N-substituted indol-3-glyoxylamid with antiasthmatic, antiallergic and immunosuppressive/immunomodulating effect |
03/25/2008 | US7348439 Chemical intermediates for polymers; contacting phenolphthalein or 2-phenyl-3,3-bis(4-hydroxyphenylphthalmidine with aniline and an acid catalyst |
03/25/2008 | US7348359 Retinoid X receptor modulators |
03/25/2008 | US7348355 Treating obesity with the Microsomal triglyceride transfer protein inhibitor (S) N-{2-[benzyl(methyl)amino]-2-oxo-1-phenylethyl}-1-methyl-5-[4'-(trifluoromethyl)[1,1'-biphenyl]-2-carboxamido]-1H-indole-2-carboxamide and another lipid lowering agent such as a statin or fibrate |
03/25/2008 | US7348354 Cyclohexylurea compounds |
03/25/2008 | US7348353 Acetylene derivatives having mGluR 5 antagonistic activity |
03/25/2008 | US7348351 for treating conditions resulting from fibrinolytic disorders such as deep vein thrombosis and coronary heart disease, and pulmonary fibrosis |
03/25/2008 | US7348338 PPAR active compounds |
03/25/2008 | US7348328 MCH antagonists for the treatment of obesity |
03/25/2008 | US7348125 Optical information recording medium and novel immonium compound |
03/25/2008 | CA2416867C Cyclopentanoindoles, compositions containing such compounds and methods of treatment |
03/25/2008 | CA2268709C Hiv protease inhibitors |
03/20/2008 | WO2008033743A1 Substituted 2-indolinone as ptk inhibitors containing a zinc binding moiety |
03/20/2008 | WO2008031811A1 Nitrate esters of aminoalcohols |
03/20/2008 | WO2008031743A1 Heterocyclic bridged biphenyls and their use in oleds |
03/20/2008 | WO2008031509A1 ISOSERINE DERIVATIVES FOR USE AS COAGULATION FACTOR IXa INHIBITORS |
03/20/2008 | US20080071095 Modulators of ATP-Binding Cassette Transporters |
03/20/2008 | US20080071094 Process for the preparation of perindopril |
03/20/2008 | US20080071091 Processes and compounds for the preparation of substituted naphthylindole derivatives |
03/20/2008 | US20080070970 Novel indole derivatives as selective androgen receptor modulators (sarms) |
03/20/2008 | US20080070954 inhibitors of histone deacetylase; antiproliferative; anticancer; 8-[3-(4-methylbenzenesulfonyl)-ureido])-octanoic acid hydroxyamide |
03/20/2008 | US20080070948 Including indanones, indolinones and benzoxazolinones containing a piperidine ring, e.g., 1-[3-(4-(Hydroxymethyl)piperidin-1-yl)propyl]-1,3-dihydrobenzoimidazol-2-one; particularly for the M1 and/or M4 receptor subtypes; increase acetylcholine signaling or effect in the brain |
03/20/2008 | US20080070789 Process for making amlodipine, derivatives thereof, and precursors therefor |
03/20/2008 | DE102007037830A1 Indolinsulfonamidverbindungen Indolinsulfonamidverbindungen |
03/20/2008 | CA2663544A1 Isoserine derivatives for use as coagulation factor ixa inhibitors |
03/20/2008 | CA2663147A1 Substituted 2-indolinone as ptk inhibitors containing a zinc binding moiety |
03/20/2008 | CA2663129A1 Nitrate esters of aminoalcohols |
03/19/2008 | EP1899300A2 Process for the synthesis of the ace inhibitor trandolapril |
03/19/2008 | EP1899299A2 C-linked cyclic antagonists of p2y1 receptor useful in the treatment of thrombotic conditions |
03/19/2008 | EP1898905A2 Hydroisoindoline tachykinin receptor antagonists |
03/19/2008 | EP1720544B1 Novel azabicyclic derivatives, preparation method thereof and pharmaceutical compositions containing same |
03/19/2008 | EP1711174B1 Adjuvant compositions |
03/19/2008 | CN101146779A Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents |
03/19/2008 | CN101146771A Process for the preparation of 2-azabicyclo[3.3.0]octane-3-carboxylic acid derivatives |
03/19/2008 | CN101146770A 2-phenyl-indoles as prostaglandin D2 receptor antagonists |
03/19/2008 | CN101143855A Method for synthesizing esters of n-[(s)-1-carboxybutyl]-(s)-alanine and use thereof for synthesizing perindopril |
03/19/2008 | CN101143830A Organic electroluminescent material and application thereof |
03/18/2008 | US7345180 Compound inhibiting dipeptidyl peptidase IV |
03/18/2008 | US7345094 Synergistic; side effect reduction; melanomas; toxicity; 2,5-Dimethoxythiobenzoic Acid N-methylhydrazine; anticancer |
03/18/2008 | US7345085 Indoles having anti-diabetic activity |
03/18/2008 | US7345084 nonsteroidal progestagens; selectivity; 6-Chloro-5-fluoro-2-phenyl-3-phenylsulfanyl-1H-indole; contraceptives; amenorrhea, dysfuntional bleeding; polycysticovarian syndrome, anticancer, side effect reduction of cyclid menstrual bleeding, food intake stimulation |
03/18/2008 | US7345083 Emesis, urinary incontinence, depression, and anxiety; substance P inhibitors; 5-{1-[3,5-bis(Trifluoromethyl)phenyl]ethoxy}-4-(4-fluorophenyl)octahydro-1H-isoindole |
03/18/2008 | US7345081 Azabicyclo-octane inhibitors of IAP |
03/18/2008 | US7345068 Aromatic amino acid derivatives and medicinal compositions |
03/18/2008 | US7345062 Substituted acylhydroxamic acids and method of reducing TNFαlevels |
03/18/2008 | CA2278313C Fluorescent cyanine dyes |
03/13/2008 | WO2008029168A2 Treatment of duchenne muscular dystrophy |
03/13/2008 | WO2008028954A2 Novel compounds and compositions thereof |
03/13/2008 | WO2007146838A3 Substituted phenyl acetic acids as dp-2 antagonists |
03/13/2008 | WO2007146547A3 Piperazine enamines as antiviral agents |
03/13/2008 | WO2007136302A8 Active substances, pharmaceutical composition and a method for the production and use thereof |
03/13/2008 | US20080064733 MAGIs (membrane associated guanylate kinase proteins with inverse orientation); oncosuppressive (tumor suppressor) protein; (2-(1-Hydroxypentyl)-3-(2-phenylethyl)-6-methyl)indole-5-carboxylic acid |
03/13/2008 | US20080064687 Vanilloid receptor modulators; analgesic, antiinflammatory and antiulcer effects; such as 1-(1H-indol-5-ylmethyl)-3-phenethylthiourea |
03/13/2008 | US20080064684 Sub-type selective serotonin receptor agonists; antidepressants; schizophrenia, Alzheimer's Disease, Parkinson's Disease; alkylation or amidation of the heterocyclylbenzazole with an alkylhalide or acylhalide |
03/13/2008 | US20080064662 Agonists having a biphenyl moiety in combination with an amide linkage at the core of the structure enhances selectivity for S1P1 receptor without causing hypotension or bradycardia; transplant rejection, autoimmune diseases; 2-Amino-N-[4-(biphenyl-4-yloxy)-phenyl]3-hydroxy-2-methyl-propionamide |
03/12/2008 | EP1897915A1 Cyanine coloring matter and optical recording medium |